Non-nucleoside structures retain full anti-HCMV potency of the dideoxy furanopyrimidine family.

about

Non-nucleoside structures retain full anti-HCMV potency of the dideoxy furanopyrimidine family.

Item

http://www.wikidata.org/entity/Q40472494

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Non-nucleoside structures reta ...... deoxy furanopyrimidine family.

@en

type

Item

label

Non-nucleoside structures reta ...... deoxy furanopyrimidine family.

@en

prefLabel

Non-nucleoside structures reta ...... deoxy furanopyrimidine family.

@en

P1476

Non-nucleoside structures reta ...... deoxy furanopyrimidine family.

@en

P2093

Olivier Bidet

http://www.w3.org/2001/XMLSchema#string

P2860

Potent and selective inhibition of varicella-zoster virus (VZV) by nucleoside analogues with an unusual bicyclic base

Furano pyrimidines as novel potent and selective anti-VZV agents.

Discovery of a new family of inhibitors of human cytomegalovirus (HCMV) based upon lipophilic alkyl furano pyrimidine dideoxy nucleosides: action via a novel non-nucleosidic mechanism.

Bicyclic pyrimidine nucleoside analogues (BCNAs) as highly selective and potent inhibitors of varicella-zoster virus replication.

2-Chloro-3-pyridin-3-yl-5,6,7,8-tetrahydroindolizine-1-carboxamide (CMV423), a new lead compound for the treatment of human cytomegalovirus infections.

Highly potent and selective inhibition of varicella-zoster virus by bicyclic furopyrimidine nucleosides bearing an aryl side chain.

Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir.

Specific recognition of the bicyclic pyrimidine nucleoside analogs, a new class of highly potent and selective inhibitors of varicella-zoster virus (VZV), by the VZV-encoded thymidine kinase.

Fluorescent bicyclic furo pyrimidine deoxynucleoside analogs as potent and selective inhibitors of VZV and potential future drugs for the treatment of chickenpox and shingles

P304

329-332

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/095632020401500605

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8084032

http://www.w3.org/2001/XMLSchema#string

P698

15646646

http://www.w3.org/2001/XMLSchema#string